Literature DB >> 17105214

Synthesis and characterization of insulin-transferrin conjugates.

Nikhil J Kavimandan1, Elena Losi, Jeffrey J Wilson, Jennifer S Brodbelt, Nicholas A Peppas.   

Abstract

Receptor-mediated endocytosis can be exploited for improving the transcellular delivery of therapeutic proteins. Insulin conjugated to transferrin by forming disulfide bonds has been shown to improve insulin oral bioavailability in diabetic rats. We are developing a combination strategy involving complexation hydrogels as delivery vehicles for insulin-transferrin conjugates. The complexation hydrogels developed in our laboratory have been shown to be promising carriers for oral delivery of proteins and peptides. Integrating the strategies based on the complexation hydrogels and insulin-transferrin conjugates may prove to be a novel approach for oral delivery of insulin and other therapeutic proteins. In this work, electrospray ionization mass spectrometry (ESI-MS) was used to study the modification of insulin during its reaction with transferrin. The stability of the conjugated insulin to enzymatic degradation was also studied. ESI-MS studies confirmed the site-specific modifications of insulin. The transferrin conjugation of insulin was also shown to increase the stability of insulin to enzymatic degradation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17105214      PMCID: PMC2547411          DOI: 10.1021/bc050344k

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  25 in total

1.  NB1-C16-insulin: site-specific synthesis, purification, and biological activity.

Authors:  H Mei; C Yu; K K Chan
Journal:  Pharm Res       Date:  1999-11       Impact factor: 4.200

Review 2.  Delivery of peptides and proteins through the blood-brain barrier.

Authors:  U Bickel; T Yoshikawa; W M Pardridge
Journal:  Adv Drug Deliv Rev       Date:  2001-03-01       Impact factor: 15.470

Review 3.  Targeted drug conjugates: principles and progress.

Authors:  M C Garnett
Journal:  Adv Drug Deliv Rev       Date:  2001-12-17       Impact factor: 15.470

4.  Comparison of monomeric and oligomeric transferrin as potential carrier in oral delivery of protein drugs.

Authors:  Ching-Jou Lim; Wei-Chiang Shen
Journal:  J Control Release       Date:  2005-09-02       Impact factor: 9.776

5.  Transcellular delivery of an insulin-transferrin conjugate in enterocyte-like Caco-2 cells.

Authors:  D Shah; W C Shen
Journal:  J Pharm Sci       Date:  1996-12       Impact factor: 3.534

6.  A fluorescence-based protein assay for use with a microplate reader.

Authors:  A Lorenzen; S W Kennedy
Journal:  Anal Biochem       Date:  1993-10       Impact factor: 3.365

7.  Hypoglycemic effect of insulin-transferrin conjugate in streptozotocin-induced diabetic rats.

Authors:  C Q Xia; J Wang; W C Shen
Journal:  J Pharmacol Exp Ther       Date:  2000-11       Impact factor: 4.030

8.  Oral delivery of insulin using pH-responsive complexation gels.

Authors:  A M Lowman; M Morishita; M Kajita; T Nagai; N A Peppas
Journal:  J Pharm Sci       Date:  1999-09       Impact factor: 3.534

9.  New coupling agents for the synthesis of immunotoxins containing a hindered disulfide bond with improved stability in vivo.

Authors:  P E Thorpe; P M Wallace; P P Knowles; M G Relf; A N Brown; G J Watson; R E Knyba; E J Wawrzynczak; D C Blakey
Journal:  Cancer Res       Date:  1987-11-15       Impact factor: 12.701

10.  Targeting anti-transferrin receptor antibody (OX26) and OX26-conjugated liposomes to brain capillary endothelial cells using in situ perfusion.

Authors:  Sara Gosk; Charlotte Vermehren; Gert Storm; Torben Moos
Journal:  J Cereb Blood Flow Metab       Date:  2004-11       Impact factor: 6.200

View more
  12 in total

1.  Confocal microscopic analysis of transport mechanisms of insulin across the cell monolayer.

Authors:  Nikhil J Kavimandan; Nicholas A Peppas
Journal:  Int J Pharm       Date:  2007-12-23       Impact factor: 5.875

Review 2.  Physicochemical and formulation developability assessment for therapeutic peptide delivery--a primer.

Authors:  Annette Bak; Dennis Leung; Stephanie E Barrett; Seth Forster; Ellen C Minnihan; Andrew W Leithead; James Cunningham; Nathalie Toussaint; Louis S Crocker
Journal:  AAPS J       Date:  2014-11-15       Impact factor: 4.009

3.  Matrix Metalloproteinase-9-Responsive Nanogels for Proximal Surface Conversion and Activated Cellular Uptake.

Authors:  Mallory R Gordon; Bo Zhao; Francesca Anson; Ann Fernandez; Khushboo Singh; Celia Homyak; Mine Canakci; Richard W Vachet; S Thayumanavan
Journal:  Biomacromolecules       Date:  2018-02-08       Impact factor: 6.988

4.  Ligand-decorated nanogels: fast one-pot synthesis and cellular targeting.

Authors:  Ja-Hyoung Ryu; Sean Bickerton; Jiaming Zhuang; S Thayumanavan
Journal:  Biomacromolecules       Date:  2012-04-11       Impact factor: 6.988

Review 5.  Overcoming barriers in non-viral gene delivery for neurological applications.

Authors:  Aaron Tasset; Arjun Bellamkonda; Wenliang Wang; Ilya Pyatnitskiy; Deidra Ward; Nicholas Peppas; Huiliang Wang
Journal:  Nanoscale       Date:  2022-03-10       Impact factor: 8.307

6.  The use of low molecular weight protamine chemical chimera to enhance monomeric insulin intestinal absorption.

Authors:  Huining He; Jianyong Sheng; Allan E David; Young Min Kwon; Jian Zhang; Yongzhuo Huang; Jianxin Wang; Victor C Yang
Journal:  Biomaterials       Date:  2013-07-14       Impact factor: 12.479

7.  Formulation, characterization and evaluation of the effect of polymer concentration on the release behavior of insulin-loaded Eudragit(®)-entrapped mucoadhesive microspheres.

Authors:  Franklin C Kenechukwu; Mumuni A Momoh
Journal:  Int J Pharm Investig       Date:  2016 Apr-Jun

8.  The Next Generation Non-competitive Active Polyester Nanosystems for Transferrin Receptor-mediated Peroral Transport Utilizing Gambogic Acid as a Ligand.

Authors:  P Saini; R Ganugula; M Arora; M N V Ravi Kumar
Journal:  Sci Rep       Date:  2016-07-08       Impact factor: 4.379

9.  Characterization and Oral Delivery of Proinsulin-Transferrin Fusion Protein Expressed Using ExpressTec.

Authors:  Yu-Sheng Chen; Jennica L Zaro; Deshui Zhang; Ning Huang; Andrew Simon; Wei-Chiang Shen
Journal:  Int J Mol Sci       Date:  2018-01-26       Impact factor: 5.923

Review 10.  Advanced delivery strategies facilitating oral absorption of heparins.

Authors:  Guihua Fang; Bo Tang
Journal:  Asian J Pharm Sci       Date:  2020-01-09       Impact factor: 6.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.